Gene · 26585
Papers2,742
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,742
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The NOR-1/SPP1/OPN axis as a driver of abdominal aortic aneurysm. | Transl Res | 2026 | 42790627 | PubTator, text mining | PubMed |
| Allele-Specific MicroRNA-Binding Variants at Colorectal Cancer Risk Loci in a Hispanic/Latino Population: An Integrative GWAS, All of Us, and Epigenomic Analysis. | medRxiv | 2026 | 42780261 | PubTator, text mining | PubMed |
| Fibroblast-derived gremlin-1 Is associated with ovarian cancer-cell phenotypes in co-culture models. | Front Oncol | 2026 | 42769056 | PubTator, text mining | PubMed |
| Profibrogenic Gremlin-1 expression in prostate cancer and the clinicopathologic association. | Front Oncol | 2026 | 42698461 | PubTator, text mining | PubMed |
| Integrative transcriptomic and experimental analysis identifies GREM1 as a pro-metastatic mediator in lung adenocarcinoma. | J Transl Med | 2026 | 42693465 | PubTator, text mining | PubMed |
| Hunting gremlins: GREM1 as a new therapeutic target for multiple diseases including glaucoma. | Pharmacol Rev | 2026 | 42691971 | PubTator, text mining | PubMed |
| Molecular insights into uterine fibroids: crosstalk between SHH and Wnt pathways, DNA methylation, and miRNAs regulation. | Mol Genet Genomics | 2026 | 42667406 | PubTator, text mining | PubMed |
| Integrative systems-level analysis identifies potential gut microbial metabolite-host signaling networks in lung adenocarcinoma. | Comput Biol Chem | 2026 | 42641424 | PubTator, text mining | PubMed |
| Links of BMP4, BMPR1A, and GREM1 expression in subcutaneous and visceral adipose tissue with metabolic syndrome and their regulation by insulin and weight loss. | Pol Arch Intern Med | 2026 | 42639863 | PubTator, text mining | PubMed |
| Age-dependent functional and transcriptional differences in intestinal mesenchymal stromal cells during early postnatal development in piglets. | Front Cell Dev Biol | 2026 | 42614535 | PubTator, text mining | PubMed |
| Artificial intelligence-derived oocyte morphology and follicular fluid biomarkers in donors. | Reproduction | 2026 | 42523187 | PubTator, text mining | PubMed |
| Serum Gremlin 1 Remains Elevated Following Successful Direct-Acting Antiviral Therapy for Chronic Hepatitis C. | Viruses | 2026 | 42515625 | PubTator, text mining | PubMed |
| Targeting chitinase-3-like protein-1 in pancolitis by a drug-repurposing approach. | Biochem Pharmacol | 2026 | 42508656 | PubTator, text mining | PubMed |
| hsa_circ_0021001 modulates human brain vascular smooth muscle cell viability in intracranial aneurysm through the miR-152-3p/GREM1 axis. | Am J Transl Res | 2026 | 42491042 | PubTator, text mining | PubMed |
| Endomyocardial Gremlin-1 is associated with structural remodeling and adverse clinical outcomes in non-ischemic cardiomyopathy. | Commun Med (Lond) | 2026 | 42393281 | PubTator, text mining | PubMed |
| SGLT2 Inhibitors Attenuate Neutrophil-Mediated Endothelial Injury in Coronary Artery Disease With Type 2 Diabetes Mellitus Through a GREM1-Associated Smad Signaling Axis. | J Cardiovasc Pharmacol | 2026 | 42359611 | PubTator, text mining | PubMed |
| C/EBP alpha agonist ICCB280 overcomes doxorubicin resistance in osteosarcoma through mitochondrial dynamics-dependent GREM1-MAPK activation. | Cell Death Dis | 2026 | 42350405 | PubTator, text mining | PubMed |
| Correction: Kim et al. Identification of GREM-1 and GAS6 as Specific Biomarkers for Cancer-Associated Fibroblasts Derived from Patients with Non-Small-Cell Lung Cancer. Cancers 2025, 17, 2858. | Cancers (Basel) | 2026 | 42279442 | PubTator, text mining | PubMed |
| GREM1/FGFR1-activated myofibroblasts induce immunosuppression and accelerate metastasis in high-grade serous ovarian cancer. | Proc Natl Acad Sci U S A | 2026 | 42268885 | PubTator, text mining | PubMed |
| Communication With Clinicians and Relatives About Cascade Genetic Testing in Cancer Patients With Germline Pathogenic Variants. | JCO Precis Oncol | 2026 | 42234943 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26585/papers